Sudeep Pharma Limited (BOM:544619)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2004	FY 2003
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2004	Mar 31, 2003
Pharmaceutical, Food and Nutrition	3.63B	3.30B	3.11B	3.30B	2.87B
Specialty Ingredients	2.80B	1.72B	1.49B	985.88M	572.51M
Total	6.42B	5.02B	4.59B	4.29B	3.45B

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2004	FY 2003
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2004	Mar 31, 2003
Others	2.93B	2.02B	1.93B	238.50M	139.65M
United States of America	918.87M	951.81M	1.03B	1.06B	852.88M
India	2.57B	2.04B	1.63B	1.35B	1.16B
Asia-Pacific	-	-	-	734.16M	537.90M
Europe	-	-	-	663.85M	516.72M
Middle East and Africa	-	-	-	237.15M	240.53M
Total	6.42B	5.02B	4.59B	4.29B	3.45B

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error